FierceCRO is moving to Mondays

FierceCRO isn't going anywhere--just shifting its schedule. From here on out, you can expect the latest in contract research and manufacturing news and analysis in your inbox each Monday, starting next week. Same coverage and features, different day. See you next week. -- Damian Garde (email | Twitter)

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.